Početna › Difuzni veliki B-stanični limfom › Ohio › Cleveland
Kliničke studije za Difuzni veliki B-stanični limfom u gradu Cleveland, OH
11 studija za Difuzni veliki B-stanični limfom traži sudionike na lokacijama u gradu Cleveland i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
U tijeku regrutacijaFaza 2
- Cleveland Clinic, Cleveland
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
U tijeku regrutacijaFaza 3
- University Hospitals Cleveland Medical Center, Cleveland
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
U tijeku regrutacijaFaza 2
- University Hospitals of Cleveland ( Site 0155), Cleveland
- Fairview Hospital-Moll Cancer Center ( Site 0198), Cleveland
- Cleveland Clinic Main ( Site 0101), Cleveland
- i još 1
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
U tijeku regrutacijaFaza 1
- Cleveland Clinic, Cleveland
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
U tijeku regrutacijaFaza 1
- Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
U tijeku regrutacijaFaza 1/2
- Cleveland Clinic, Cleveland
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
U tijeku regrutacijaFaza 3
- Cleveland Clinical Taussig Cancer Center, Cleveland
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
U tijeku regrutacijaFaza 1
- Case Western Reserve University, Cleveland
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
U tijeku regrutacijaFaza 1
- Cleveland Clinic, Cleveland
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
U tijeku regrutacijaFaza 2
- Case Western Reserve University, Cleveland
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
U tijeku regrutacijaFaza 1
- University Hospitals Cleveland Medical Center, Cleveland
Studije za Difuzni veliki B-stanični limfom u drugim gradovima
- New York City, NY21 studija
- Baldwin Park, CA19 studija
- Chicago, IL18 studija
- Houston, TX17 studija
- Los Angeles, CA17 studija
- Boston, MA16 studija
- Milwaukee, WI16 studija
- Nashville, TN15 studija
- Portland, OR15 studija
- Philadelphia, PA15 studija
- Durham, NC14 studija
- Dallas, TX13 studija
Ostale studije u gradu Cleveland
- Nemikrocelularni karcinom pluća43 studija
- Rak (sve vrste)36 studija
- Rak dojke35 studija
- Rak prostate34 studija
- Srčano zatajenje33 studija
- Metastatski karcinom30 studija
- Rak jajnika30 studija
- Rak pluća26 studija
- Kolorektalni rak24 studija
- Kardiovaskularne bolesti22 studija
- Rak endometrija20 studija
- Akutna mijeloična leukemija20 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.